Table 3: Community Pharmacist’s Perception of Pharmacovigilance and ADR Reporting (n=42)

RESPONSES
DISAGREE NEUTRAL AGREE
PRE POS PRE POS PRE POS Median Median
Survey Statements F (%) F (%) F (%) F (%) F (%) F (%) PRE POS P Value*
I do not have any idea on how to report ADR to the relevant authorities in Malaysia 17 (19.0) 37 ( 88.1 ) 4 (9.5) 2 (4.8 ) 22 (50.0) 3 (11.9 ) 3(2-5) 2(1-2) <0.001
I hardly see any adr cases in my practice 16 (38.1) 27 (64.2 ) 13 (31.10) 10 ( 23.8) 13 (31.0) 5 ( 11.9) 3(2-4) 2(2-3) 0.026
ADRs reporting in Malaysia is not widely promoted by relevant authorities 5 (11.9) 4 (9.5 ) 15 (35.7) 9 (21.4) 22 (52.4) 28 (66.6 ) 4(3-4) 4(3-4) 0.589
ADRs reporting in Malaysia needs to be simplified 3 (7.2) 3 ( 5.2) 19 (45.2) 12 ( 28.6) 20 (47.6) 27 (64.3 ) 3(3-4) 4(3-4) 0.377
Information on how report adr is needed 2 (4.8) 1 (2.4 ) 6 (14.3) 3 (7.1 ) 34 (61.0) 38 ( 90.5) 4(4-5) 4(4-5) 0.126
My present knowledge in ADRs limit my ability to detect and report adr 7 (16.7) 19 (45.2 ) 12 (28.6) 7 (16.7 ) 32 (54.8) 16 (38.1) 4(3-4) 3(2-4) 0.004

F= Frequency, PRE= Pre-test, POS= Post-test.